Benzinga's Top Downgrades

Analysts at JP Morgan downgraded ViroPharma (NASDAQ: VPHM) from “overweight” to “neutral.” The target price for ViroPharma has been raised from $45 to $50. ViroPharma's shares closed at $49.42 yesterday.

Analysts at Canaccord Genuity downgraded Hologic (NASDAQ: HOLX) from “buy” to “hold.” The target price for Hologic has been lowered to $19. Hologic's shares closed at $22.90 yesterday.

Analysts at Macquarie downgraded Symantec (NASDAQ: SYMC) from “outperform” to “neutral.” The target price for Symantec has been lowered to $24. Symantec's shares closed at $23.21 yesterday.

UBS downgraded Gogo (NASDAQ: GOGO) from “buy” to “neutral.” Gogo's shares closed at $24.15 yesterday.